Jun 03, 2020 / 08:00PM GMT
Unidentified Participant
It is my pleasure to introduce Alexandra Deschner, Investor Relations Officer at Mithra Pharmaceuticals, to present at the Jefferies Virtual Healthcare Conference.
Alexandra Deschner - Mithra Pharmaceuticals SA - IR Officer
Thank you very much, Robert. Welcome and thank you for joining me for this introduction to Mithra. Before I begin I would like to remind you that I'll be making some forward-looking statements throughout this presentation which are associated with certain risks. I urge you to read and familiarize yourself with the Safe Harbor statement.
To begin, Mithra is a Belgian biotech specialized in women's health, namely contraception and menopause. We were founded in 1999 and have celebrated our 20th year anniversary just last year. Listed on the Euronext Brussels in 2015, it was the most successful IPO in the eurozone in that year.
Currently we have over 250 staff members, which I highlight because it's more than four times the number we had at IPO, and we are growing up to 300 staff this year as we near
Mithra Pharmaceuticals SA at Jefferies Healthcare Conference (Virtual) Transcript
Mar 01, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers